J&J booster 85% effective against hospitalisation by Omicron for 1-2 months - S.African study | CredoWeb

Artículo

J&J booster 85% effective against hospitalisation by Omicron for 1-2 months - S.African study

J&J booster 85% effective against hospitalisation by Omicron for 1-2 months - S.African study

Esta publicación es para usuarios registrados

Please register or log in with your account to read the full publication.

COVID-19

booster Omicron J&J

Compartir:

Comentarios

Ver otras publicaciones de este autor

Heart patients set to receive treatment tailored to their genetic and health information

Intravascular imaging associated with improved outcomes compared with angiography

Ver todas las publicaciones del autor